David I Chu1,2, Tiebin Liu3, Priya Patel4, Jonathan C Routh5, Lijing Ouyang3, Michelle A Baum6, Earl Y Cheng1, Elizabeth B Yerkes1, Tamara Isakova7,8. 1. Division of Urology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 2. Center for Healthcare Studies, Feinberg School of Medicine at Northwestern University, Chicago, Illinois. 3. Centers for Disease Control and Prevention, Atlanta, Georgia. 4. Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee. 5. Division of Urology, Duke University School of Medicine, Durham, North Carolina. 6. Division of Nephrology, Boston Children's Hospital, Boston, Massachusetts. 7. Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Feinberg School of Medicine at Northwestern University, Chicago, Illinois. 8. Division of Nephrology and Hypertension, Feinberg School of Medicine at Northwestern University, Chicago, Illinois.
Abstract
PURPOSE: Chronic kidney disease affects 25% to 50% of patients with spina bifida. Guidelines recommend kidney function surveillance in these patients but practice patterns are unknown. Variations in kidney function surveillance were assessed in patients with spina bifida based on the hypothesis that the treating clinic and spina bifida type would be associated with kidney function surveillance. MATERIALS AND METHODS: A retrospective cohort study was conducted of U.S. patients in the National Spina Bifida Patient Registry from 2013 to 2018. Followup was anchored at the 2013 visit. Participants with either an outcome event within 2 years of followup or more than 2 years of followup without an outcome event were included. Primary outcome was kidney function surveillance, defined as at least 1 renal ultrasound and serum creatinine within 2 years of followup. Primary exposures were clinic and spina bifida type, which were analyzed with covariates including sociodemographic and clinical characteristics in logistic regression models for their association with the outcome. Sensitivity analyses were performed using different kidney function surveillance definitions. RESULTS: Of 8,351 patients 5,445 were included with a median followup of 3.0 years. Across 23 treating clinics kidney function surveillance rates averaged 62% (range 6% to 100%). In multivariable models kidney function surveillance was associated with treating clinic, younger patient age, functional lesion level, nonambulatory status and prior bladder augmentation. Treating clinic remained a significant predictor of kidney function surveillance in all sensitivity analyses. CONCLUSIONS: Within the National Spina Bifida Patient Registry wide variation exists in practice of kidney function surveillance across treating clinics despite adjustment for key patient characteristics.
PURPOSE:Chronic kidney disease affects 25% to 50% of patients with spina bifida. Guidelines recommend kidney function surveillance in these patients but practice patterns are unknown. Variations in kidney function surveillance were assessed in patients with spina bifida based on the hypothesis that the treating clinic and spina bifida type would be associated with kidney function surveillance. MATERIALS AND METHODS: A retrospective cohort study was conducted of U.S. patients in the National Spina Bifida Patient Registry from 2013 to 2018. Followup was anchored at the 2013 visit. Participants with either an outcome event within 2 years of followup or more than 2 years of followup without an outcome event were included. Primary outcome was kidney function surveillance, defined as at least 1 renal ultrasound and serum creatinine within 2 years of followup. Primary exposures were clinic and spina bifida type, which were analyzed with covariates including sociodemographic and clinical characteristics in logistic regression models for their association with the outcome. Sensitivity analyses were performed using different kidney function surveillance definitions. RESULTS: Of 8,351 patients 5,445 were included with a median followup of 3.0 years. Across 23 treating clinics kidney function surveillance rates averaged 62% (range 6% to 100%). In multivariable models kidney function surveillance was associated with treating clinic, younger patient age, functional lesion level, nonambulatory status and prior bladder augmentation. Treating clinic remained a significant predictor of kidney function surveillance in all sensitivity analyses. CONCLUSIONS: Within the National Spina Bifida Patient Registry wide variation exists in practice of kidney function surveillance across treating clinics despite adjustment for key patient characteristics.
Authors: Paul R Womble; Susan M Linsell; Yuqing Gao; Zaojun Ye; James E Montie; Tejal N Gandhi; Brian R Lane; Frank N Burks; David C Miller Journal: J Urol Date: 2015-04-17 Impact factor: 7.450
Authors: David I Chu; Lauren C Balmert; Cameron M Arkin; Theresa Meyer; Ilina Rosoklija; Belinda Li; Kavita S Hodgkins; Susan L Furth; Earl Y Cheng; Elizabeth B Yerkes; Tamara Isakova Journal: Neurourol Urodyn Date: 2019-07-08 Impact factor: 2.696
Authors: Anna Jander; Michaeł Nowicki; Marcin Tkaczyk; Maria Roszkowska-Blaim; Tomasz Jarmoliński; Ewa Marczak; Ewa Pałuba; Jacek A Pietrzyk; Grzegorz Siteń; Roman Stankiewicz; Krystyna Szprynger; Maria Zajaczkowska; J Zachwieja; W Zoch-Zwierz; D Zwolińska Journal: Nephrol Dial Transplant Date: 2005-12-08 Impact factor: 5.992
Authors: Amy N Luckenbaugh; Gregory B Auffenberg; Scott R Hawken; Apoorv Dhir; Susan Linsell; Sanjeev Kaul; David C Miller Journal: J Urol Date: 2016-09-20 Impact factor: 7.450
Authors: Judy K Thibadeau; Elisabeth A Ward; Minn M Soe; Tiebin Liu; Mark Swanson; Kathleen J Sawin; Kurt A Freeman; Heidi Castillo; Karen Rauen; Michael S Schechter Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-11-02
Authors: James T Rague; Jeremy D Lai; Peggy Murphy; Andrea Fawcett; Ryan Walton; Ilina Rosoklija; Diana K Bowen; Elizabeth B Yerkes; Earl Y Cheng; Kavita S Hodgkins; Jonathan C Routh; Tamara Isakova; David I Chu Journal: J Urol Date: 2022-01-20 Impact factor: 7.600